These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25855109)

  • 1. A randomized trial of hospital vs home self administration of vaginal misoprostol for medical abortion.
    Shrestha A; Sedhai LB
    Kathmandu Univ Med J (KUMJ); 2014; 12(47):185-9. PubMed ID: 25855109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
    Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
    Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
    Mittal S; Agarwal S; Kumar S; Batra A
    Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
    el-Refaey H; Templeton A
    Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.
    Creinin MD; Carbonell JL; Schwartz JL; Varela L; Tanda R
    Contraception; 1999 Jan; 59(1):11-6. PubMed ID: 10342081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.
    Wong KS; Ngai CS; Wong AY; Tang LC; Ho PC
    Contraception; 1998 Oct; 58(4):207-10. PubMed ID: 9866000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
    Oppegaard KS; Qvigstad E; Nesheim BI
    BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
    Schaff EA; Fielding SL; Westhoff C
    Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.